Vanda Pharmaceuticals Announces Participation at November 2024 Investor Conferences
Vanda Pharmaceuticals Announces Participation at November 2024 Investor Conferences
The corporate presentation and fireside chat given at the Stifel and Jefferies conferences, respectively, may be accessed live on Vanda's corporate website, . Investors should click on the Investors tab and follow the links under Recent Events. Investors are advised to go to the conference websites at least 15 minutes early to register, download, and install any necessary software or presentations. Links to the archived conferences will be available on Vanda's website for a period of approximately 30 days.WASHINGTON, Nov. 12, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the following upcoming investor conferences in November 2024:
華盛頓，2024年11月12日/美通社/ - 凡達製藥公司（Vanda）（納斯達克： 納斯達克代碼VNDA）今日宣佈，公司將參加2024年11月的以下投資者會議：
The Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024. A corporate presentation is scheduled for 9:45 a.m. Eastern Time.
2024年11月19日星期二，參加Stifel 2024醫療保健會議。公司演示將於東部時間上午9:45開始。
The Jefferies 2024 London Healthcare Conference on Thursday, November 21, 2024. A fireside chat is scheduled for 11:30 a.m. Greenwich Mean Time (6:30 a.m. Eastern Time).
2024年11月21日星期四，參加Jefferies 2024倫敦醫療保健會議。爐邊談話安排在格林威治時間上午11:30進行（東部時間上午6:30）。
The corporate presentation and fireside chat given at the Stifel and Jefferies conferences, respectively, may be accessed live on Vanda's corporate website, . Investors should click on the Investors tab and follow the links under Recent Events. Investors are advised to go to the conference websites at least 15 minutes early to register, download, and install any necessary software or presentations. Links to the archived conferences will be available on Vanda's website for a period of approximately 30 days.
在Stifel和Jefferies會議上進行的公司演示和爐邊談話可以在凡達公司的網站上實時訪問。投資者應單擊「投資者」選項卡，並在「最近事件」下查看鏈接。建議投資者至少提前15分鐘登錄會議網站進行註冊、下載和安裝所需軟件或演示文稿。大約30天內，會議的存檔鏈接將在凡達公司的網站上提供。
About Vanda Pharmaceuticals Inc.
關於Vanda製藥公司。Vanda是一家領先的全球生物製藥公司，專注於開發和商業化創新療法以解決高度未滿足的醫療需求，並改善患者生活。欲了解更多有關Vanda製藥公司的信息，請訪問網站並關注我們的X @vandapharma。
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit and follow us on X @vandapharma.
Vanda是一家領先的全球生物製藥公司，專注於開發和商業化創新療法，以解決高度未滿足的醫療需求，並改善患者的生活。如需了解更多關於Vanda Pharmaceuticals Inc.的信息，請訪問並關注我們在X上的賬號@vandapharma。
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
[email protected]
公司聯繫人:
Kevin Moran。
高級副總裁、 致富金融(臨時代碼)和財務主管
萬達製藥公司。
202-734-3400
[email protected]
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
[email protected]
吉姆·高登/傑克·凱利赫爾/丹·摩爾
1-212-379-2072
[email protected]
SOURCE Vanda Pharmaceuticals Inc.
資料來源: Vanda Pharmaceuticals Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
想要您公司的新聞在PRNEWSWIRE.COM上特色呈現嗎？
譯文內容由第三人軟體翻譯。
